EU Laws On Medicines Supply To Northern Ireland Move Closer
Draft legislation that would avoid post-Brexit regulatory problems for medicines moving between Great Britain and Northern Ireland is on course for formal adoption.
You may also be interested in...
CytoDyn In Damage-Control Mode (Again) With Clinical Holds For Leronlimab
Troubled leronlimab is placed on partial clinical hold in HIV, full clinical hold in COVID-19. While searching for a new CEO, CytoDyn tries to reassure investors about its business plan going forward.
Navigating The UK's Post-Brexit Regulatory Complexities
The UK regulator explains the new requirements for batch testing and release in Great Britain and Northern Ireland, what's involved in importing clinical trial drugs to Northern Ireland, and what factors determine the location of the Qualified Person.
Canada Proposes List Of ‘Critical Products’ & More Agile Regulation To Address Shortages
The Canadian government says stakeholders are “poised for action” to improve the collective response to drug shortages and has come up with some questions and possible answers as to how best to go about it.